Filed: 11/14/2025ACC: 0001892688-25-000193
📋 What this filing means
DIADEMA PARTNERS LP filed this quarterly 13F‑HR report disclosing 106 equity positions with a total reported market value of $390.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
106
Positions
$390.97M
Total AUM (reported)
23.05M
Total Shares
Allocation by class
COM$260.57M66.6%
COM NEW$26.17M6.7%
SHS$26.03M6.7%
SHS USD$22.82M5.8%
TR UNIT$13.32M3.4%
NAMEN AKT$7.26M1.9%
ADR$6.94M1.8%
Portfolio Concentration
Top 3$62.46M16.0%
4–10$90.47M23.1%
11–25$107.60M27.5%
Rest$130.44M33.4%
Top 3 weight
16.0%
Top 10 weight
39.1%
Voting Authority Distribution
Total shares with voting rights: 23.05M
Sole
Full voting authority
23.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole106
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings106
Rows:
JAZZ PHARMACEUTICALS PLC
SOLEShares173.14K
TypeSH
Market value$22.82M
5.84%
Sole
173.14K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares327.33K
TypeSH
Market value$22.13M
5.66%
Sole
327.33K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares300K
TypeSH
Market value$17.51M
4.48%
Sole
300K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares30.16K
TypeSH
Market value$16.96M
4.34%
Sole
30.16K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares598.79K
TypeSH
Market value$15.74M
4.02%
Sole
598.79K
Shared
0.00
None
0.00
BRISTOL-MYERS SQUIBB CO
SOLEShares310K
TypeSH
Market value$13.98M
3.58%
Sole
310K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares20K
TypeSH
Market value$13.32M
3.41%
Sole
20K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares212.88K
TypeSH
Market value$11.53M
2.95%
Sole
212.88K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares230.10K
TypeSH
Market value$10.03M
2.56%
Sole
230.10K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares222.10K
TypeSH
Market value$8.92M
2.28%
Sole
222.10K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares282.49K
TypeSH
Market value$8.50M
2.17%
Sole
282.49K
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares100K
TypeSH
Market value$8.48M
2.17%
Sole
100K
Shared
0.00
None
0.00
INTELLIA THERAPEUTICS INC
SOLEShares470.20K
TypeSH
Market value$8.12M
2.08%
Sole
470.20K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares218.28K
TypeSH
Market value$7.86M
2.01%
Sole
218.28K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares10K
TypeSH
Market value$7.63M
1.95%
Sole
10K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares191.65K
TypeSH
Market value$7.61M
1.95%
Sole
191.65K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares112K
TypeSH
Market value$7.26M
1.86%
Sole
112K
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares125K
TypeSH
Market value$6.94M
1.77%
Sole
125K
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares250.10K
TypeSH
Market value$6.89M
1.76%
Sole
250.10K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares131.40K
TypeSH
Market value$6.82M
1.75%
Sole
131.40K
Shared
0.00
None
0.00
MANNKIND CORP
SOLEShares1.25M
TypeSH
Market value$6.72M
1.72%
Sole
1.25M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$6.54M
1.67%
Sole
100K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares420K
TypeSH
Market value$6.35M
1.63%
Sole
420K
Shared
0.00
None
0.00
INDIVIOR PLC
SOLEShares254.25K
TypeSH
Market value$6.13M
1.57%
Sole
254.25K
Shared
0.00
None
0.00
MODERNA INC
SOLEShares222.10K
TypeSH
Market value$5.74M
1.47%
Sole
222.10K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 173.14K | SH | $22.82M 5.84% | 173.14K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 327.33K | SH | $22.13M 5.66% | 327.33K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 300K | SH | $17.51M 4.48% | 300K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 30.16K | SH | $16.96M 4.34% | 30.16K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 598.79K | SH | $15.74M 4.02% | 598.79K | 0.00 | 0.00 |
BRISTOL-MYERS SQUIBB COSOLE | COM | 310K | SH | $13.98M 3.58% | 310K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 20K | SH | $13.32M 3.41% | 20K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 212.88K | SH | $11.53M 2.95% | 212.88K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 230.10K | SH | $10.03M 2.56% | 230.10K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 222.10K | SH | $8.92M 2.28% | 222.10K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 282.49K | SH | $8.50M 2.17% | 282.49K | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 100K | SH | $8.48M 2.17% | 100K | 0.00 | 0.00 |
INTELLIA THERAPEUTICS INCSOLE | COM | 470.20K | SH | $8.12M 2.08% | 470.20K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 218.28K | SH | $7.86M 2.01% | 218.28K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 10K | SH | $7.63M 1.95% | 10K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 191.65K | SH | $7.61M 1.95% | 191.65K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 112K | SH | $7.26M 1.86% | 112K | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 125K | SH | $6.94M 1.77% | 125K | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 250.10K | SH | $6.89M 1.76% | 250.10K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 131.40K | SH | $6.82M 1.75% | 131.40K | 0.00 | 0.00 |
MANNKIND CORPSOLE | COM NEW | 1.25M | SH | $6.72M 1.72% | 1.25M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 100K | SH | $6.54M 1.67% | 100K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 420K | SH | $6.35M 1.63% | 420K | 0.00 | 0.00 |
INDIVIOR PLCSOLE | ORD | 254.25K | SH | $6.13M 1.57% | 254.25K | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 222.10K | SH | $5.74M 1.47% | 222.10K | 0.00 | 0.00 |
Page 1 of 5
…